论文部分内容阅读
为研究已行最大限度减瘤术的Ⅲ期上皮性卵巢癌,在化疗期间运用腹盆腔CT扫描是否具有监测病情发展的作用。对1989年～1992年68例,Ⅲ期上皮性卵巢癌行成功减瘤术后施以铂类为基础的联合化疗。所有患者在术前及各疗程化疗结束后均作盆腔体检和血清CA125检测,并分别在术前、第3和第6疗程化疗后进行CT扫描。其中60例为1组行二次探查术,另8例为2组因肿瘤已进展而未行二探术。 1组在二探术前所有临床检查均显示肿瘤缓解。
To investigate whether stage III epithelial ovarian cancer has been performed with minimal cytoreductive surgery, the use of abdominal pelvic CT scanning during chemotherapy has the effect of monitoring the progression of the disease. Eighty-eight cases from 1989 to 1992 were treated with platinum-based chemotherapy after successful tumor reduction in stage III epithelial ovarian cancer. All patients underwent pelvic examination and serum CA125 examination before surgery and after each course of chemotherapy. CT scans were performed before and after the 3rd and 6th courses of chemotherapy. Among them, 60 patients had a second exploration operation in group 1, and 8 patients in group 2 had no probing because of tumor progression. All the clinical examinations of group 1 showed tumor remission before the second exploration.